Improving Rare Disease Clinical Trial Design
Clincierge CEO Scott Gray recently spoke to PM360 about strategies to improve rare disease clinical trial design.
Clincierge CEO Scott Gray recently spoke to PM360 about strategies to improve rare disease clinical trial design.